Why Royal Dutch Shell Plc, AstraZeneca plc and Antofagasta plc Should Lag The FTSE 100 Today

Royal Dutch Shell Plc (LON: RDSB), AstraZeneca plc (LON: AZN) and Antofagasta plc (LON: ANTO) are having a down day.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 (FTSEINDICES: ^FTSE) is retreating a little after five sessions of rises in a row, losing 32 points to 6,746 by noon. Although London’s top index has been buoyed in recent days by positive earnings, disappointing results from some of its star members lie behind today’s reversal.

We take a look at three companies holding the FTSE 100 back today:

Royal Dutch Shell

A disappointing performance miss from Royal Dutch Shell sent its shares down 109p (4.8%) to 2,168p this morning. Third-quarter earnings on a current-cost-of-supplies (CCS) basis crashed 32%, to $4.2bn from $6.2bn a year previously — a fall had been expected, but not one that big.

Also on a CCS basis, earnings per share excluding exceptional items fell 32% from a year ago, to 71 cents per share — but Shell’s quarterly dividend has been raised 5% to 45 cents per share.

Chief executive Peter Voser said “We are facing headwinds from weak industry refining margins, and the security situation in Nigeria, which continue to erode the near term outlook“, but reiterated that Shell is committed to rewarding its shareholders through dividends.

AstraZeneca

A third-quarter update from AstraZeneca also caused disappointment, with loss of exclusivity on several drug brands leading to an expected 4% fall in revenue to $6,250m. But that fall, compounded with increased research investment, led to a 20% fall in pre-tax profit to $1,592m and a 16% drop in earnings per share to 99 cents.

But on the upside, the company told us its late-stage pipeline is continuing to grow, with candidates olaparib, selumetinib and benralizumab all progressing to the Phase III clinical programme stage.

Today’s drop takes AstraZeneca shares to a P/E of 10.6 based on full-year forecasts — with a 5.5% dividend yield predicted, could they be a bargain now?

Antofagasta

Our third FTSE 100 faller today is Antofagasta (LSE: AZN), after investors reacted negatively to the copper miner’s Q3 production report.

Volumes of the brown metal were in line with expectations, with 174,200 tonnes of the stuff produced in the quarter — 3.4% down on the previous quarter, but 4.4% up year-to-date. And though output fell 11.7% on the quarter to 67,700 ounces, year-to-date production rose 8% to 230,600 ounces.

Forecasts for the full year are unchanged, but fears of a surplus of copper over the next few years pushing prices down further is what hit the share price today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

> Alan does not own any shares mentioned in this article.

More on Investing Articles

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Where will the Tesla share price be 5 years from now?

With robotaxis set to be unveiled next month, could ARK Invest be right in thinking the Tesla share price is…

Read more »

Investing Articles

Here’s the dividend forecast for Rolls-Royce shares

Rolls-Royce shares have generated market-beating returns for investors over the past two years. But it's also planning to reinstate its…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

This lesser-known US dividend stock has a P/E of 8.5 and a 13.2% yield

This American tanker company offers an industry-topping dividend yield. Dr James Fox explores whether this dividend stock is worth watching.

Read more »

Investing Articles

Why passive income investors should look at UK shares

Higher dividend yields, lower taxes, and reduced currency risks are three reasons for UK investors to look close to home…

Read more »

Dividend Shares

If I only bought dividend stocks for my ISA, here’s how much passive income I could make

Jon Smith explains how he could get to £1k a month in passive income by investing his full ISA allowance…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

Hargreaves Lansdown investors are buying Nvidia stock via an ETP and it’s risky

Nvidia stock has a lot of potential. But investing in it via a leveraged exchange-traded product could be very risky,…

Read more »

Older couple walking in park
Investing Articles

What’s going on with the Phoenix Group share price?

The Phoenix Group share price has had a rough time lately, down nearly 20% in five years. But with shifting…

Read more »

Investing Articles

After crashing 35% and 76% these FTSE value shares yield 12% and 10%. Be careful!

After a torrid year these two FTSE 250 value shares now have double-digit yields. Or so Harvey Jones thought until…

Read more »